A major shift in Czech medical policy is changing how chronic pain is treated—opening the door to new possibilities.
A major change in medical regulations is set to transform how chronic pain is treated in the Czech Republic. A new policy introduced on April 1 broadens the scope of who can provide certain prescriptions, significantly affecting patient care.
Until now, access to this treatment was tightly controlled, requiring patients to seek out specialists. Though legally available for nearly a decade, its use remained limited due to strict prescribing regulations. The latest update allows more medical professionals to offer this option, potentially reducing reliance on conventional painkillers such as morphine and fentanyl.
To support the transition, a nationwide training initiative has been launched, featuring seminars designed to educate doctors on best practices.
Despite a slow start when first introduced in 2015, prescriptions have steadily increased. In 2021, over 100 kilograms were dispensed, and by 2024, that number had tripled to 320 kilograms—accounting for over a third of the total distributed since legalization. Over the past decade, 250 doctors have prescribed nearly 937 kilograms. Additionally, the 2024 Report on Illegal Drugs in the Czech Republic found that up to 25% of individuals over age 15 have turned to this treatment for self-medication.
Financial accessibility has also improved in recent years. Since 2020, health insurers have covered up to 90% of the cost, capping reimbursement at 30 grams per month. In 2022 alone, the General Health Insurance Company paid CZK 17.2 million for this type of care, benefiting around 3,200 patients.
The updated regulations extend eligibility to minors with terminal or oncological conditions, ensuring access as part of palliative care. Currently, this treatment is authorized for chronic pain and specific medical conditions, including:
-
Pain caused by cancer, degenerative musculoskeletal diseases, and other long-term illnesses.
-
Neurological tremors linked to Parkinson’s disease.
-
Spasticity associated with multiple sclerosis, spinal cord injuries, and conditions affecting mobility or respiration.
-
Gilles de la Tourette syndrome.
-
Nausea, vomiting, and appetite loss due to chemotherapy or HIV.
-
Certain skin and mucosal conditions.
While the policy expands prescribing authority, certain restrictions remain in place. The Ministry of Health has clarified that for conditions beyond chronic pain—such as neurological disorders and cancer-related symptoms—patients will still need to consult specialists.
If you're interested in collaborating with us, feel free to share your suggestions, including those related to the places we review, or notify us about any events by sending an email to expat247@outlook.com.
